カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界のDTPワクチン市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global DTP Vaccine Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19280）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19280
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：113
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界のDTPワクチン市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

DTPワクチン市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のDTPワクチンの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

DTPワクチン市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・百日咳、ジフテリア、破傷風

用途別セグメントは次のように区分されます。
・病院、防疫所、村の保健室

世界のDTPワクチン市場の主要な市場プレーヤーは以下のとおりです。
・SANOFI PASTEUR、NOVARTIS、Vaxelis、GSK、Serum Institute of India、Johnson & Johnson、Merck Sharp & Dohme Corp、Seqirus、Pfizer、Astrazeneca、astellas、Emergent BioSolutions Inc、WALVAX、Wuhan Institute of Biological Products Co.,Ltd.、Chengdu Institute of Biological Products Co.,Ltd.

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、DTPワクチン製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なDTPワクチンメーカーの企業概要、2019年～2022年までのDTPワクチンの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なDTPワクチンメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別DTPワクチンの販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのDTPワクチンの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのDTPワクチン市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびDTPワクチンの産業チェーンを掲載しています。
・第13、14、15章では、DTPワクチンの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- DTPワクチンの概要
- 種類別分析（2017年vs2021年vs2028年）：百日咳、ジフテリア、破傷風
- 用途別分析（2017年vs2021年vs2028年）：病院、防疫所、村の保健室
- 世界のDTPワクチン市場規模・予測
- 世界のDTPワクチン生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- SANOFI PASTEUR、NOVARTIS、Vaxelis、GSK、Serum Institute of India、Johnson & Johnson、Merck Sharp & Dohme Corp、Seqirus、Pfizer、Astrazeneca、astellas、Emergent BioSolutions Inc、WALVAX、Wuhan Institute of Biological Products Co.,Ltd.、Chengdu Institute of Biological Products Co.,Ltd.
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：百日咳、ジフテリア、破傷風
・用途別分析2017年-2028年：病院、防疫所、村の保健室
・DTPワクチンの北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・DTPワクチンのヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・DTPワクチンのアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・DTPワクチンの南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・DTPワクチンの中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The DTP Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global DTP Vaccine market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during forecast period 2022-2028. Hospital accounting for % of the DTP Vaccine global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Pertussis segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of DTP Vaccine include SANOFI PASTEUR, NOVARTIS, Vaxelis, GSK, and Serum Institute of India, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
DTP Vaccine market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Pertussis
Diphtheria
Tetanus
Market segment by Application can be divided into
Hospital
Epidemic Prevention Station
Village Health Room
The key market players for global DTP Vaccine market are listed below:
SANOFI PASTEUR
NOVARTIS
Vaxelis
GSK
Serum Institute of India
Johnson & Johnson
Merck Sharp & Dohme Corp
Seqirus
Pfizer
Astrazeneca
astellas
Emergent BioSolutions Inc
WALVAX
Wuhan Institute of Biological Products Co.,Ltd.
Chengdu Institute of Biological Products Co.,Ltd.
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe DTP Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of DTP Vaccine, with price, sales, revenue and global market share of DTP Vaccine from 2019 to 2022.
Chapter 3, the DTP Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the DTP Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and DTP Vaccine market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of DTP Vaccine.
Chapter 13, 14, and 15, to describe DTP Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 DTP Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global DTP Vaccine Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Pertussis
1.2.3 Diphtheria
1.2.4 Tetanus
1.3 Market Analysis by Application
1.3.1 Overview: Global DTP Vaccine Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Epidemic Prevention Station
1.3.4 Village Health Room
1.4 Global DTP Vaccine Market Size & Forecast
1.4.1 Global DTP Vaccine Sales in Value (2017 & 2021 & 2028)
1.4.2 Global DTP Vaccine Sales in Volume (2017-2028)
1.4.3 Global DTP Vaccine Price (2017-2028)
1.5 Global DTP Vaccine Production Capacity Analysis
1.5.1 Global DTP Vaccine Total Production Capacity (2017-2028)
1.5.2 Global DTP Vaccine Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 DTP Vaccine Market Drivers
1.6.2 DTP Vaccine Market Restraints
1.6.3 DTP Vaccine Trends Analysis
2 Manufacturers Profiles
2.1 SANOFI PASTEUR
2.1.1 SANOFI PASTEUR Details
2.1.2 SANOFI PASTEUR Major Business
2.1.3 SANOFI PASTEUR DTP Vaccine Product and Services
2.1.4 SANOFI PASTEUR DTP Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 NOVARTIS
2.2.1 NOVARTIS Details
2.2.2 NOVARTIS Major Business
2.2.3 NOVARTIS DTP Vaccine Product and Services
2.2.4 NOVARTIS DTP Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Vaxelis
2.3.1 Vaxelis Details
2.3.2 Vaxelis Major Business
2.3.3 Vaxelis DTP Vaccine Product and Services
2.3.4 Vaxelis DTP Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 GSK
2.4.1 GSK Details
2.4.2 GSK Major Business
2.4.3 GSK DTP Vaccine Product and Services
2.4.4 GSK DTP Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Serum Institute of India
2.5.1 Serum Institute of India Details
2.5.2 Serum Institute of India Major Business
2.5.3 Serum Institute of India DTP Vaccine Product and Services
2.5.4 Serum Institute of India DTP Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Johnson & Johnson
2.6.1 Johnson & Johnson Details
2.6.2 Johnson & Johnson Major Business
2.6.3 Johnson & Johnson DTP Vaccine Product and Services
2.6.4 Johnson & Johnson DTP Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Merck Sharp & Dohme Corp
2.7.1 Merck Sharp & Dohme Corp Details
2.7.2 Merck Sharp & Dohme Corp Major Business
2.7.3 Merck Sharp & Dohme Corp DTP Vaccine Product and Services
2.7.4 Merck Sharp & Dohme Corp DTP Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Seqirus
2.8.1 Seqirus Details
2.8.2 Seqirus Major Business
2.8.3 Seqirus DTP Vaccine Product and Services
2.8.4 Seqirus DTP Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Pfizer
2.9.1 Pfizer Details
2.9.2 Pfizer Major Business
2.9.3 Pfizer DTP Vaccine Product and Services
2.9.4 Pfizer DTP Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Astrazeneca
2.10.1 Astrazeneca Details
2.10.2 Astrazeneca Major Business
2.10.3 Astrazeneca DTP Vaccine Product and Services
2.10.4 Astrazeneca DTP Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 astellas
2.11.1 astellas Details
2.11.2 astellas Major Business
2.11.3 astellas DTP Vaccine Product and Services
2.11.4 astellas DTP Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Emergent BioSolutions Inc
2.12.1 Emergent BioSolutions Inc Details
2.12.2 Emergent BioSolutions Inc Major Business
2.12.3 Emergent BioSolutions Inc DTP Vaccine Product and Services
2.12.4 Emergent BioSolutions Inc DTP Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 WALVAX
2.13.1 WALVAX Details
2.13.2 WALVAX Major Business
2.13.3 WALVAX DTP Vaccine Product and Services
2.13.4 WALVAX DTP Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Wuhan Institute of Biological Products Co.,Ltd.
2.14.1 Wuhan Institute of Biological Products Co.,Ltd. Details
2.14.2 Wuhan Institute of Biological Products Co.,Ltd. Major Business
2.14.3 Wuhan Institute of Biological Products Co.,Ltd. DTP Vaccine Product and Services
2.14.4 Wuhan Institute of Biological Products Co.,Ltd. DTP Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Chengdu Institute of Biological Products Co.,Ltd.
2.15.1 Chengdu Institute of Biological Products Co.,Ltd. Details
2.15.2 Chengdu Institute of Biological Products Co.,Ltd. Major Business
2.15.3 Chengdu Institute of Biological Products Co.,Ltd. DTP Vaccine Product and Services
2.15.4 Chengdu Institute of Biological Products Co.,Ltd. DTP Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 DTP Vaccine Breakdown Data by Manufacturer
3.1 Global DTP Vaccine Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global DTP Vaccine Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in DTP Vaccine
3.4 Market Concentration Rate
3.4.1 Top 3 DTP Vaccine Manufacturer Market Share in 2021
3.4.2 Top 6 DTP Vaccine Manufacturer Market Share in 2021
3.5 Global DTP Vaccine Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and DTP Vaccine Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global DTP Vaccine Market Size by Region
4.1.1 Global DTP Vaccine Sales in Volume by Region (2017-2028)
4.1.2 Global DTP Vaccine Revenue by Region (2017-2028)
4.2 North America DTP Vaccine Revenue (2017-2028)
4.3 Europe DTP Vaccine Revenue (2017-2028)
4.4 Asia-Pacific DTP Vaccine Revenue (2017-2028)
4.5 South America DTP Vaccine Revenue (2017-2028)
4.6 Middle East and Africa DTP Vaccine Revenue (2017-2028)
5 Market Segment by Type
5.1 Global DTP Vaccine Sales in Volume by Type (2017-2028)
5.2 Global DTP Vaccine Revenue by Type (2017-2028)
5.3 Global DTP Vaccine Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global DTP Vaccine Sales in Volume by Application (2017-2028)
6.2 Global DTP Vaccine Revenue by Application (2017-2028)
6.3 Global DTP Vaccine Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America DTP Vaccine Sales by Type (2017-2028)
7.2 North America DTP Vaccine Sales by Application (2017-2028)
7.3 North America DTP Vaccine Market Size by Country
7.3.1 North America DTP Vaccine Sales in Volume by Country (2017-2028)
7.3.2 North America DTP Vaccine Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe DTP Vaccine Sales by Type (2017-2028)
8.2 Europe DTP Vaccine Sales by Application (2017-2028)
8.3 Europe DTP Vaccine Market Size by Country
8.3.1 Europe DTP Vaccine Sales in Volume by Country (2017-2028)
8.3.2 Europe DTP Vaccine Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific DTP Vaccine Sales by Type (2017-2028)
9.2 Asia-Pacific DTP Vaccine Sales by Application (2017-2028)
9.3 Asia-Pacific DTP Vaccine Market Size by Region
9.3.1 Asia-Pacific DTP Vaccine Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific DTP Vaccine Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America DTP Vaccine Sales by Type (2017-2028)
10.2 South America DTP Vaccine Sales by Application (2017-2028)
10.3 South America DTP Vaccine Market Size by Country
10.3.1 South America DTP Vaccine Sales in Volume by Country (2017-2028)
10.3.2 South America DTP Vaccine Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa DTP Vaccine Sales by Type (2017-2028)
11.2 Middle East & Africa DTP Vaccine Sales by Application (2017-2028)
11.3 Middle East & Africa DTP Vaccine Market Size by Country
11.3.1 Middle East & Africa DTP Vaccine Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa DTP Vaccine Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of DTP Vaccine and Key Manufacturers
12.2 Manufacturing Costs Percentage of DTP Vaccine
12.3 DTP Vaccine Production Process
12.4 DTP Vaccine Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 DTP Vaccine Typical Distributors
13.3 DTP Vaccine Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global DTP Vaccine Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global DTP Vaccine Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. SANOFI PASTEUR Basic Information, Manufacturing Base and Competitors
Table 4. SANOFI PASTEUR Major Business
Table 5. SANOFI PASTEUR DTP Vaccine Product and Services
Table 6. SANOFI PASTEUR DTP Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. NOVARTIS Basic Information, Manufacturing Base and Competitors
Table 8. NOVARTIS Major Business
Table 9. NOVARTIS DTP Vaccine Product and Services
Table 10. NOVARTIS DTP Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Vaxelis Basic Information, Manufacturing Base and Competitors
Table 12. Vaxelis Major Business
Table 13. Vaxelis DTP Vaccine Product and Services
Table 14. Vaxelis DTP Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. GSK Basic Information, Manufacturing Base and Competitors
Table 16. GSK Major Business
Table 17. GSK DTP Vaccine Product and Services
Table 18. GSK DTP Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Serum Institute of India Basic Information, Manufacturing Base and Competitors
Table 20. Serum Institute of India Major Business
Table 21. Serum Institute of India DTP Vaccine Product and Services
Table 22. Serum Institute of India DTP Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 24. Johnson & Johnson Major Business
Table 25. Johnson & Johnson DTP Vaccine Product and Services
Table 26. Johnson & Johnson DTP Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Merck Sharp & Dohme Corp Basic Information, Manufacturing Base and Competitors
Table 28. Merck Sharp & Dohme Corp Major Business
Table 29. Merck Sharp & Dohme Corp DTP Vaccine Product and Services
Table 30. Merck Sharp & Dohme Corp DTP Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Seqirus Basic Information, Manufacturing Base and Competitors
Table 32. Seqirus Major Business
Table 33. Seqirus DTP Vaccine Product and Services
Table 34. Seqirus DTP Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Pfizer Basic Information, Manufacturing Base and Competitors
Table 36. Pfizer Major Business
Table 37. Pfizer DTP Vaccine Product and Services
Table 38. Pfizer DTP Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Astrazeneca Basic Information, Manufacturing Base and Competitors
Table 40. Astrazeneca Major Business
Table 41. Astrazeneca DTP Vaccine Product and Services
Table 42. Astrazeneca DTP Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. astellas Basic Information, Manufacturing Base and Competitors
Table 44. astellas Major Business
Table 45. astellas DTP Vaccine Product and Services
Table 46. astellas DTP Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Emergent BioSolutions Inc Basic Information, Manufacturing Base and Competitors
Table 48. Emergent BioSolutions Inc Major Business
Table 49. Emergent BioSolutions Inc DTP Vaccine Product and Services
Table 50. Emergent BioSolutions Inc DTP Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. WALVAX Basic Information, Manufacturing Base and Competitors
Table 52. WALVAX Major Business
Table 53. WALVAX DTP Vaccine Product and Services
Table 54. WALVAX DTP Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. Wuhan Institute of Biological Products Co.,Ltd. Basic Information, Manufacturing Base and Competitors
Table 56. Wuhan Institute of Biological Products Co.,Ltd. Major Business
Table 57. Wuhan Institute of Biological Products Co.,Ltd. DTP Vaccine Product and Services
Table 58. Wuhan Institute of Biological Products Co.,Ltd. DTP Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. Chengdu Institute of Biological Products Co.,Ltd. Basic Information, Manufacturing Base and Competitors
Table 60. Chengdu Institute of Biological Products Co.,Ltd. Major Business
Table 61. Chengdu Institute of Biological Products Co.,Ltd. DTP Vaccine Product and Services
Table 62. Chengdu Institute of Biological Products Co.,Ltd. DTP Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 63. Global DTP Vaccine Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 64. Global DTP Vaccine Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 65. Market Position of Manufacturers in DTP Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 66. Global DTP Vaccine Production Capacity by Company, (K Units): 2020 VS 2021
Table 67. Head Office and DTP Vaccine Production Site of Key Manufacturer
Table 68. DTP Vaccine New Entrant and Capacity Expansion Plans
Table 69. DTP Vaccine Mergers & Acquisitions in the Past Five Years
Table 70. Global DTP Vaccine Sales by Region (2017-2022) & (K Units)
Table 71. Global DTP Vaccine Sales by Region (2023-2028) & (K Units)
Table 72. Global DTP Vaccine Revenue by Region (2017-2022) & (USD Million)
Table 73. Global DTP Vaccine Revenue by Region (2023-2028) & (USD Million)
Table 74. Global DTP Vaccine Sales by Type (2017-2022) & (K Units)
Table 75. Global DTP Vaccine Sales by Type (2023-2028) & (K Units)
Table 76. Global DTP Vaccine Revenue by Type (2017-2022) & (USD Million)
Table 77. Global DTP Vaccine Revenue by Type (2023-2028) & (USD Million)
Table 78. Global DTP Vaccine Price by Type (2017-2022) & (US$/Unit)
Table 79. Global DTP Vaccine Price by Type (2023-2028) & (US$/Unit)
Table 80. Global DTP Vaccine Sales by Application (2017-2022) & (K Units)
Table 81. Global DTP Vaccine Sales by Application (2023-2028) & (K Units)
Table 82. Global DTP Vaccine Revenue by Application (2017-2022) & (USD Million)
Table 83. Global DTP Vaccine Revenue by Application (2023-2028) & (USD Million)
Table 84. Global DTP Vaccine Price by Application (2017-2022) & (US$/Unit)
Table 85. Global DTP Vaccine Price by Application (2023-2028) & (US$/Unit)
Table 86. North America DTP Vaccine Sales by Country (2017-2022) & (K Units)
Table 87. North America DTP Vaccine Sales by Country (2023-2028) & (K Units)
Table 88. North America DTP Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 89. North America DTP Vaccine Revenue by Country (2023-2028) & (USD Million)
Table 90. North America DTP Vaccine Sales by Type (2017-2022) & (K Units)
Table 91. North America DTP Vaccine Sales by Type (2023-2028) & (K Units)
Table 92. North America DTP Vaccine Sales by Application (2017-2022) & (K Units)
Table 93. North America DTP Vaccine Sales by Application (2023-2028) & (K Units)
Table 94. Europe DTP Vaccine Sales by Country (2017-2022) & (K Units)
Table 95. Europe DTP Vaccine Sales by Country (2023-2028) & (K Units)
Table 96. Europe DTP Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 97. Europe DTP Vaccine Revenue by Country (2023-2028) & (USD Million)
Table 98. Europe DTP Vaccine Sales by Type (2017-2022) & (K Units)
Table 99. Europe DTP Vaccine Sales by Type (2023-2028) & (K Units)
Table 100. Europe DTP Vaccine Sales by Application (2017-2022) & (K Units)
Table 101. Europe DTP Vaccine Sales by Application (2023-2028) & (K Units)
Table 102. Asia-Pacific DTP Vaccine Sales by Region (2017-2022) & (K Units)
Table 103. Asia-Pacific DTP Vaccine Sales by Region (2023-2028) & (K Units)
Table 104. Asia-Pacific DTP Vaccine Revenue by Region (2017-2022) & (USD Million)
Table 105. Asia-Pacific DTP Vaccine Revenue by Region (2023-2028) & (USD Million)
Table 106. Asia-Pacific DTP Vaccine Sales by Type (2017-2022) & (K Units)
Table 107. Asia-Pacific DTP Vaccine Sales by Type (2023-2028) & (K Units)
Table 108. Asia-Pacific DTP Vaccine Sales by Application (2017-2022) & (K Units)
Table 109. Asia-Pacific DTP Vaccine Sales by Application (2023-2028) & (K Units)
Table 110. South America DTP Vaccine Sales by Country (2017-2022) & (K Units)
Table 111. South America DTP Vaccine Sales by Country (2023-2028) & (K Units)
Table 112. South America DTP Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 113. South America DTP Vaccine Revenue by Country (2023-2028) & (USD Million)
Table 114. South America DTP Vaccine Sales by Type (2017-2022) & (K Units)
Table 115. South America DTP Vaccine Sales by Type (2023-2028) & (K Units)
Table 116. South America DTP Vaccine Sales by Application (2017-2022) & (K Units)
Table 117. South America DTP Vaccine Sales by Application (2023-2028) & (K Units)
Table 118. Middle East & Africa DTP Vaccine Sales by Region (2017-2022) & (K Units)
Table 119. Middle East & Africa DTP Vaccine Sales by Region (2023-2028) & (K Units)
Table 120. Middle East & Africa DTP Vaccine Revenue by Region (2017-2022) & (USD Million)
Table 121. Middle East & Africa DTP Vaccine Revenue by Region (2023-2028) & (USD Million)
Table 122. Middle East & Africa DTP Vaccine Sales by Type (2017-2022) & (K Units)
Table 123. Middle East & Africa DTP Vaccine Sales by Type (2023-2028) & (K Units)
Table 124. Middle East & Africa DTP Vaccine Sales by Application (2017-2022) & (K Units)
Table 125. Middle East & Africa DTP Vaccine Sales by Application (2023-2028) & (K Units)
Table 126. DTP Vaccine Raw Material
Table 127. Key Manufacturers of DTP Vaccine Raw Materials
Table 128. Direct Channel Pros & Cons
Table 129. Indirect Channel Pros & Cons
Table 130. DTP Vaccine Typical Distributors
Table 131. DTP Vaccine Typical Customers
List of Figures
Figure 1. DTP Vaccine Picture
Figure 2. Global DTP Vaccine Revenue Market Share by Type in 2021
Figure 3. Pertussis
Figure 4. Diphtheria
Figure 5. Tetanus
Figure 6. Global DTP Vaccine Revenue Market Share by Application in 2021
Figure 7. Hospital
Figure 8. Epidemic Prevention Station
Figure 9. Village Health Room
Figure 10. Global DTP Vaccine Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 11. Global DTP Vaccine Revenue and Forecast (2017-2028) & (USD Million)
Figure 12. Global DTP Vaccine Sales (2017-2028) & (K Units)
Figure 13. Global DTP Vaccine Price (2017-2028) & (US$/Unit)
Figure 14. Global DTP Vaccine Production Capacity (2017-2028) & (K Units)
Figure 15. Global DTP Vaccine Production Capacity by Geographic Region: 2022 VS 2028
Figure 16. DTP Vaccine Market Drivers
Figure 17. DTP Vaccine Market Restraints
Figure 18. DTP Vaccine Market Trends
Figure 19. Global DTP Vaccine Sales Market Share by Manufacturer in 2021
Figure 20. Global DTP Vaccine Revenue Market Share by Manufacturer in 2021
Figure 21. DTP Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 22. Top 3 DTP Vaccine Manufacturer (Revenue) Market Share in 2021
Figure 23. Top 6 DTP Vaccine Manufacturer (Revenue) Market Share in 2021
Figure 24. Global DTP Vaccine Sales Market Share by Region (2017-2028)
Figure 25. Global DTP Vaccine Revenue Market Share by Region (2017-2028)
Figure 26. North America DTP Vaccine Revenue (2017-2028) & (USD Million)
Figure 27. Europe DTP Vaccine Revenue (2017-2028) & (USD Million)
Figure 28. Asia-Pacific DTP Vaccine Revenue (2017-2028) & (USD Million)
Figure 29. South America DTP Vaccine Revenue (2017-2028) & (USD Million)
Figure 30. Middle East & Africa DTP Vaccine Revenue (2017-2028) & (USD Million)
Figure 31. Global DTP Vaccine Sales Market Share by Type (2017-2028)
Figure 32. Global DTP Vaccine Revenue Market Share by Type (2017-2028)
Figure 33. Global DTP Vaccine Price by Type (2017-2028) & (US$/Unit)
Figure 34. Global DTP Vaccine Sales Market Share by Application (2017-2028)
Figure 35. Global DTP Vaccine Revenue Market Share by Application (2017-2028)
Figure 36. Global DTP Vaccine Price by Application (2017-2028) & (US$/Unit)
Figure 37. North America DTP Vaccine Sales Market Share by Type (2017-2028)
Figure 38. North America DTP Vaccine Sales Market Share by Application (2017-2028)
Figure 39. North America DTP Vaccine Sales Market Share by Country (2017-2028)
Figure 40. North America DTP Vaccine Revenue Market Share by Country (2017-2028)
Figure 41. United States DTP Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Canada DTP Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Mexico DTP Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Europe DTP Vaccine Sales Market Share by Type (2017-2028)
Figure 45. Europe DTP Vaccine Sales Market Share by Application (2017-2028)
Figure 46. Europe DTP Vaccine Sales Market Share by Country (2017-2028)
Figure 47. Europe DTP Vaccine Revenue Market Share by Country (2017-2028)
Figure 48. Germany DTP Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. France DTP Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. United Kingdom DTP Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Russia DTP Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Italy DTP Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Asia-Pacific DTP Vaccine Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific DTP Vaccine Sales Market Share by Application (2017-2028)
Figure 55. Asia-Pacific DTP Vaccine Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific DTP Vaccine Revenue Market Share by Region (2017-2028)
Figure 57. China DTP Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Japan DTP Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Korea DTP Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. India DTP Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Southeast Asia DTP Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Australia DTP Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. South America DTP Vaccine Sales Market Share by Type (2017-2028)
Figure 64. South America DTP Vaccine Sales Market Share by Application (2017-2028)
Figure 65. South America DTP Vaccine Sales Market Share by Country (2017-2028)
Figure 66. South America DTP Vaccine Revenue Market Share by Country (2017-2028)
Figure 67. Brazil DTP Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Argentina DTP Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Middle East & Africa DTP Vaccine Sales Market Share by Type (2017-2028)
Figure 70. Middle East & Africa DTP Vaccine Sales Market Share by Application (2017-2028)
Figure 71. Middle East & Africa DTP Vaccine Sales Market Share by Region (2017-2028)
Figure 72. Middle East & Africa DTP Vaccine Revenue Market Share by Region (2017-2028)
Figure 73. Turkey DTP Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Egypt DTP Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Saudi Arabia DTP Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. South Africa DTP Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Manufacturing Cost Structure Analysis of DTP Vaccine in 2021
Figure 78. Manufacturing Process Analysis of DTP Vaccine
Figure 79. DTP Vaccine Industrial Chain
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
Figure 81. Methodology
Figure 82. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界のA型肝炎及びB型肝炎用混合ワクチン市場2022年：市場規模予測（～2028年）
  • 世界の肺炎球菌ワクチン多価市場2022年：市場規模予測（～2028年）
  • アジュバント使用インフルエンザワクチンのグローバル市場展望 2023年-2029年：バイアル、充填済み
  • 世界の獣医用ウイルスベクター化ワクチン市場2022年：市場規模予測（～2028年）
  • 世界のIPVワクチン市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19280 )"世界のDTPワクチン市場2022年：市場規模予測（～2028年）" (英文：Global DTP Vaccine Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。